Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 1
1960 3
1962 1
1966 1
1972 1
1973 1
1974 1
1975 3
1976 5
1977 4
1978 8
1979 6
1980 1
1981 3
1982 4
1983 8
1984 8
1985 6
1986 8
1987 7
1988 5
1989 15
1990 17
1991 18
1992 10
1993 15
1994 19
1995 14
1996 17
1997 15
1998 11
1999 12
2000 13
2001 12
2002 10
2003 15
2004 13
2005 19
2006 18
2007 25
2008 21
2009 24
2010 20
2011 24
2012 45
2013 43
2014 38
2015 59
2016 62
2017 55
2018 57
2019 29
2020 30
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

861 results
Results by year
Filters applied: . Clear all
Page 1
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A. Vogelmeier CF, et al. Among authors: fabbri lm. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP. Am J Respir Crit Care Med. 2017. PMID: 28128970 Free article.
Inhaled corticosteroids in COPD: friend or foe?
Agusti A, Fabbri LM, Singh D, Vestbo J, Celli B, Franssen FME, Rabe KF, Papi A. Agusti A, et al. Among authors: fabbri lm. Eur Respir J. 2018 Dec 13;52(6):1801219. doi: 10.1183/13993003.01219-2018. Print 2018 Dec. Eur Respir J. 2018. PMID: 30190269 Free article. Review.
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.
Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B. Vanfleteren L, et al. Among authors: fabbri lm. Int J Chron Obstruct Pulmon Dis. 2018 Dec 12;13:3971-3981. doi: 10.2147/COPD.S185975. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30587953 Free PMC article. Review.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Vestbo J, et al. Among authors: fabbri lm. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Am J Respir Crit Care Med. 2013. PMID: 22878278 Review.
Triple therapy with budesonide/glycopyrrolate/formoterol fumarate with co-suspension delivery technology versus dual therapies in chronic obstructive pulmonary disease (KRONOS): a double-blind, parallel-group, multicentre, phase 3 randomised controlled trial.
Ferguson GT, Rabe KF, Martinez FJ, Fabbri LM, Wang C, Ichinose M, Bourne E, Ballal S, Darken P, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C. Ferguson GT, et al. Among authors: fabbri lm. Lancet Respir Med. 2018 Oct;6(10):747-758. doi: 10.1016/S2213-2600(18)30327-8. Epub 2018 Sep 16. Lancet Respir Med. 2018. PMID: 30232048 Clinical Trial.
Chronic cough in adults.
Spanevello A, Beghé B, Visca D, Fabbri LM, Papi A. Spanevello A, et al. Among authors: fabbri lm. Eur J Intern Med. 2020 Aug;78:8-16. doi: 10.1016/j.ejim.2020.03.018. Epub 2020 May 17. Eur J Intern Med. 2020. PMID: 32434660 Review.
Asthma progression and mortality: the role of inhaled corticosteroids.
O'Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P. O'Byrne P, et al. Among authors: fabbri lm. Eur Respir J. 2019 Jul 18;54(1):1900491. doi: 10.1183/13993003.00491-2019. Print 2019 Jul. Eur Respir J. 2019. PMID: 31048346 Free PMC article. Review.
Management of chronic refractory cough in adults.
Visca D, Beghè B, Fabbri LM, Papi A, Spanevello A. Visca D, et al. Among authors: fabbri lm. Eur J Intern Med. 2020 Nov;81:15-21. doi: 10.1016/j.ejim.2020.09.008. Epub 2020 Sep 19. Eur J Intern Med. 2020. PMID: 32958373 Free PMC article. Review.
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G, Guasconi A, Montagna I, Vezzoli S, Petruzzelli S, Scuri M, Roche N, Singh D. Papi A, et al. Among authors: fabbri l. Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.
861 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page